NCT06246370

Brief Summary

The aim of this study is to investigate cervical region biomechanics, muscle performance and respiratory muscle strength in patients with Chronic Obstructive Pulmonary Disease (COPD) compared to healthy subjects.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
34

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 11, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

February 7, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

February 20, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 6, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 6, 2025

Completed
Last Updated

February 7, 2024

Status Verified

January 1, 2024

Enrollment Period

7 months

First QC Date

October 11, 2023

Last Update Submit

January 30, 2024

Conditions

Outcome Measures

Primary Outcomes (9)

  • Evaluation of sagittal cobb angle

    Cobb anle will measure from X-ray imagination between T2- T12 level.

    day 1

  • Cranial rotation angle

    Tragus- eye horizontal angle will measure from lateral cervical photographs.

    day 1

  • evaluation of cervical region biomechanic (dynamic)

    Investigation of the cervical region range of motions of cervical flexion, cervical extension, cervical lateral flexion, and cervical rotation range of motion.

    day 1

  • cervical inclination angle

    tragus eye and C7 level horizontal angle will measure from lateral cervical photographs.

    day 1

  • cervical lateral flexion angle

    the angle between pogonion-tragus and C7 level will measure from lateral cervical photographs.

    day 1

  • Shoulder elevation/depression angle

    the angle between acromion- C7 level and horizontal line will measure from lateral cervical photographs.

    day 1

  • chest wall analysis

    the distance between 3rd, 7th and 9th ribs and horizontal line will measure from X-Ray

    day 1

  • rib angle

    Sternum and 4th,5th, 6th rib will mark and the angle between these and maximum anteroposteror dimention of the thorax will measure from X-Ray.

    day 1

  • diaphragma height

    the distance between T1- and L2 level will measure from X-Ray.

    day 1

Secondary Outcomes (15)

  • postural analysis

    day 1

  • respiratory muscle strength

    day 1

  • cervical region muscle strength and endurance

    day 1

  • airway flow limitation

    day 1

  • management of cough

    day 1

  • +10 more secondary outcomes

Study Arms (2)

COPD group

patients with COPD aged 40 years and above.

control group

aged matced healty patients

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients referred by the department of chest diseases of Hacettepe university will be taken

You may qualify if:

  • Being diagnosed with stage 1-2-3-4 according to the Classification of Airflow Limitation in COPD (GOLD) system,
  • Being \>40 years old,
  • Being cognitively competent to understand and answer evaluation questions.
  • Being clinically stable for the last 4 weeks,
  • Being under control of accompanying comorbid conditions (such as hypertension, diabetes),
  • Volunteering to participate in the research.

You may not qualify if:

  • Having been hospitalized due to exacerbation in the last 3 months,
  • Having a musculoskeletal, neurological, rheumatological or oncological disease that affects the craniocervical \& cervicothoracic joints and/or may prevent evaluation,
  • Having undergone any surgical intervention on the craniocervicofacial region and spine in the last six months,
  • Having lung malignancy, neoplasm, adenocarcinoma,
  • Being a lung cancer patient or having received cancer treatment (head and neck lung radiotherapy), having undergone pneumonectemia, lobectomy or resection surgery,
  • Being treated for anxiety and depression,
  • Having scoliosis,
  • Having a congenital anomaly of the craniocervicofacial region.
  • Having 3 out of 4 findings according to the diagnostic criteria for cervical radiculopathy,
  • Having thoracic outlet syndrome (TOS)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University, Health Sciences Faculty

Ankara, 06100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveNeck PainCough

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsRespiration DisordersSigns and Symptoms, Respiratory

Study Officials

  • Aynur Demirel

    Hacettepe University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PT, PhD, Assoc. Prof.

Study Record Dates

First Submitted

October 11, 2023

First Posted

February 7, 2024

Study Start

February 20, 2024

Primary Completion

September 6, 2024

Study Completion

September 6, 2025

Last Updated

February 7, 2024

Record last verified: 2024-01

Locations